Moderna, Pfizer, J&J talk omicron response


Cover picture for the articleAs COVID-19's new omicron variant has begun to emerge overseas, vaccine makers Moderna, Pfizer and Johnson & Johnson have outlined their respective strategies to tackle the new strain. Moderna, which has an authorized booster dose at the 50 microgram (µg) dose level for adults ages 18 years or older,...

Comments / 2

Comments / 0